Verba Medica - s這wnik medyczny online angielsko - polski, polsko - angielski
  Najwi瘯szy - 95780 hase (47890 polskich, 47890 angielskich)

Archiwum hase

Apple mosaic virus {ApMV} | Arabis mosaic virus {ArMV} | Index of Consciousness {IoC} | positive allosteric modulation {PAM} | sundown syndrome, | dry eye disease {DED} | Meibomian gland | intraocular pressure (IOP) | tear film break-up time (TFBUT) | adeno-associated viruses {AVV} | posttranscriptional gene silencing {PTGS} | cold shock proteins {Csp} | site- directected mutagenesis | site- specific mutagenesis | null mutation | Post-Transcriptional Gene Silencing {PTGS} | Virus Induced Gene Silencing {VIGS} | Helper virus | Continuous positive airway pressure {CPAP} | High-flow nasal cannula {HFNC} | non-invasive positive pressure ventilation {NIPPV} | intermittent positive pressure ventilation {IPPV} | Transcriptional Gene Silencing {TGS} | high-frequency jet ventilation | Sickle-cell anaemia {SCA} | Suppression Subtractive Hybridization {SSH} | colony-forming unit {CFU} | Obstructive sleep apnea {OSA} | Functional Residual Capacity {FRC} | Ventricular rhythm | Non-esterified fatty acids {NEFA} | replication cycle of HCV | direct acting antivirals {DAAs} | Early virological response {EVR} | Host targeting agents {HTAs} | interferon stimulated genes | Rapid virogical response {RVR} | Sustained virological response {SVR} | Untranslated region {UTR} | Japanese encephalitis {JE} | japanese encephalitis virus {JEV} | Scintillation proximity assay {SPA} | central venous catheter {CVC} | Body Temperature Pressure Saturated {BTPS} | chronic heart failure | valvular heart disease | High Altitude Pulmonary Edema {HAPE} | critical limb ischemia | silent myocardial ischemia  | oxidative stress biomarkers | ischemia-reperfusion injury | Neutrophil infiltration  | oxidative stress | Dual Anti-platelet Therapy {DAT} | mural thrombus | Neurofibrosarcoma {NFS} | DNA minor groove | histone deacetylase inhibitor | histone deacetylase inhibitor {HDI} | Nuclear export signal {NES} | intratumoral administration {ITu} | Thebesian valve | valve of the coronary sinus | Familial hypobetalipoproteinaemia {(FHBL} | Metabolic syndrome {MS} | Somatotrophin axis hormones | bone anabolism | alkaline phosphatase isoenzyme | Bone mineral density {BMD} | Scarff-Bloom-Richardson grading system {SBR} | triple negative breast cancer {TNBC} | bone turnover marker | Mitral stenosis | cephalgia | Renin angiotensin system {RAS} | Pulmonary arterial hypertension {PAH} | Precapillary pulmonary hypertension | Mean pulmonary artery pressure {MAP} | pulmonary capillary wedge pressure {PCWP} | pulmonary vascular resistance {PVR} | Chronic thromboembolic pulmonary hypertension (CTEPH) | Persistent pulmonary hypertension of the newborn {PPHN} | Pulmonary veno-occlusive disease {PVOD} | Hepatic veno-occlusive disease {VOD} | Pulmonary capillary hemangiomatosis {PCH} | Interstitial lung disease | Myeloproliferative syndromes. | Pulmonary Langerhans' cell histiocytosis {PLCH} | glycogen storage diseases {GSD} | normoxia | chronic hypoxia, | Lysosomal Storage Disorders {LSD} | Very low density lipoproteins {VLDL} | Subacute cutaneous lupus erythematosus {SCLE} | Epigenetics  | glomerular filtration rate {GFR} | Neutrophil Extracellular Trap {NET} | collagen induced arthritis | Murray Valley encephalitis virus {MVEV} | Omsk hemorrhagic fever {OHF} | Anticitrillinated protein antibodies {ACPA} | Neutrophilic dermatoses {ND} | Rapid virological response {RVR} | Direct acting antivirals {DAA} | triple-negative breast cancer {TNBC} | Lipid-based delivery systems (LBDDS} | Self-emulsifying drug delivery systems {SEDDS} | therapeutic index {TI} | Antibody dependent cell mediated cytotoxicity {ADCC} | Complementarity-determining regions {CDR} | Complement-dependent cytotoxicity {CDC} | Receptor activator for nuclear factor kB ligand {RANKL} | Cytotoxic T-lymphocyte antygen 4antygen {CTLA4} | Graft versus host disease {GVHD} | Membrane attack complex {MAC} | Non-acute rejection episode {NONARE} | Complement-dependent cytolysis {CDC} | Bernard-Soulier syndrome {BSS} | Giant platelet syndrome  | Sialidase activity | neuraminidase inhibitor | Inhaled corticosteroids {ICS) | small airways | Mitochondrial antiviral signaling protein {MAVS} | Caspase activation and recruitment domain {CARD} | exponential growing phase | conditional senescence | Archaeons | methanogenic microorganisms | Canalicular multispecific organic anion transporter {CMOAT} | multidrug resistance related protein {MRP} | Membrane spanning domain {MSD} | Prostatic intraepithelial neoplasia {PIN} | substrate specificity | extracellular vesicles {EV} | Duodenum-preserving pancreatic head resection {DPPHR} | Adoptive cell transfer (ACT) | Chimeric antygen receptor {CAR} | Artificial antigen presenting cells {aAPC} | multimodality therapy | Regulatory T cells {Tregs} | Myeloid-derived suppressor cells {MDSC} | Mmantle cell lymphoma {MCL} | Autologous stem cell transplantation {ASCT} | T-cell infiltrating lymphocytes {TIL} | Dental Pulp Stem Cells {DPSC} | Stem Ce lls from Human Exfoliated Deciduous teeth {SHED} | Neuron specific enolase {NSE} | lactose operon | area under the curve {AUC} | Progression free survival {PFS} | non-receptor tyrosine kinase | Prokaryotic expression system | Multiple Cloning Sites {MCS} | origin of replication {ori} | nuclear polyhedrosis virus {NPV} | Molecularly imprinted polymers {MIPs} | Chronic allograft nephropathy {CAN} | metaphyseal | Spondylo-epi-metaphyseal dysplasias {SEMD} | Hepatosplenic gamma - delta cell lymphoma  | Angioimmunoblastic Lymphadenopathy with Dysproteinemia {AILD} | primary myxedema | membrane glycoprotein | angioimmunoblastic lymphoma | cold ischemia time | Panel reactive antibody {PRA} | organ donation | fatal acute poisoning | Cerebrovascular accident {CVA} | Hemolytic – Uremic Syndrome  | thrombotic thrombocytopenic purpura {TTP} | Antibody-mediated renal allograft rejection | estimated glomerular filtration rate {eGFR} | Methicyllin-resistant Staphylococcus epidermidis {MRSE} | tubular atrophy{TA} | polyoma virus associated nephropathy {PVAN} | subclinical acute rejection {SCAR} | anti-body mediated rejection {ABMR} | Expanded criteria donor {ECD} | Deceased-donor score {DDS} | cadaveric donor | Donor specific antibodies {DSA} | Acute rejection episode {ARE}  | human leukocyte antigen {HLA} | mixed lymphocyte reaction {MLR} | Cardio-renal syndrome  | Cold ischemia time {CIT} | Donor after cardiac death {DCD} | Warm ischemic time {WIT} | Ischemia-reperfusion injury {IRI} | Posttransplant diabetes mellitus {PTDM}  | fasting plasma glucose {FPG} | acute metabolic decompensation | hypertriglyceridemia  | low-molecular heparin | Common Toxicity Criteria {CTC} | blood urea nitrogen {BUN} | Hemolytic uremic syndrom {HUS} | Glucocorticoid response element {GRE} |
Poprzednia    1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56   57   58   59   60   61   62   63   64   65   66   67   68   69   70   71   72   73   74   75   76   77   78   79   80   81   82   83   84   85   86   87   88   89   90   91   92   93   94   95   96   97   98   99   100   101   102   103   104   105   106   107   108   109   110   111   112   113   114   115   116   117   118   119   120   121   122   123   124   125   126   127   128   129   130   131   132   133   134   135   136   137   138   139   140   141   142   143   144   145   146   147   148   149   150   151   152   153   154   155   156   157   158   159   160   161   162   163   164   165   166   167   168   169   170   171   172   173   174   175   176   177   178   179   180   181   182   183   184   185   186   187   188   189   190   191   192   193   194   195   196   197   198   199   200   201   202   203   204   205   206   207   208   209   210   211   212   213   214   215   216   217   218   219   220   221   222   223   224   225   226   227   228   229   230   231   232   233   234   235   236   237   238   239   240    Nast瘼na
Copyright © 2014 verba-medica.pl. Wszystkie prawa zastrze穎ne. | Regulamin | Polityka prywatno軼i